Market Scenario:
Melanoma is a type of cancer that develops from pigment
containing cells known as melanocytes. It is the most dangerous type of skin
cancer. Sometimes they develop from moles showing significant change in color,
increase in size, itchiness, irregular edges, changein color or skin breakdown.
Exposure to ultra violet light in people with low pigment levels. The tumor can
be either malignant or benign. Types of melanoma are superficial spreading
melanoma, nodular melanoma, lentigo maglina melanoma, acral lentigious melanoma
and others. About 98% of melanoma is localized in the US. Skin cancer are most
common cancers in the US. Treatment available for melanoma include biologic
therapy, immune therapy, radiation therapy, chemotherapy and surgery. Ultra
violet exposure is known as risk factor of melanoma. Superficial spreading
melanoma is the type of melanoma affecting large number of people in the US.
The disease is more common in men than women.
Get Sample
Copy @ https://www.marketresearchfuture.com/sample_request/2950
The US market of melanoma is expected to reach US$ 3.2
billion in 2023 from US$ 2.4 billion in 2016 with a CAGR of approximately 8.3%.
Market Synopsis of Melanoma Market Share by Type, 2016 (%):
Market Synopsis of Melanoma Market Share by Type, 2016 (%):
Study Objectives of Melanoma Market:
- To provide detailed analysis of the market structure
along with forecast for the next six years of various segments and
sub-segments of the melanoma market.
- To provide insights about factors affecting the
market’s growth.
- To analyze the melanoma market based on various factors
price analysis, supply chain analysis, Porters Five Force analysis etc.
- To provide historical and forecast revenue of the
market segments and sub-segments with respect to the US.
- To provide country level analysis of the market with
respect to the current market size and future prospective.
- To provide country level analysis of the market for
segments by type, by end users and its sub-segments.
- To provide overview of key players and their strategic
profiling in the market, comprehensively analyzing their core
competencies, and drawing a competitive landscape for the market.
- To track and analyze competitive developments such as
joint ventures, strategic alliances, mergers and acquisitions, new product
developments, and research and developments in the US melanoma market.
Intended Audience
- Hospitals
- Pharmaceutical companies
- Research and development (R&D) companies
- Academic medical institutes and universities
- Melanoma drug manufactures
- Melanoma drug suppliers
Segments:
US melanoma market has been
segmented on the basis of type (superficial spreading, nodular, lentigo
maglina, acral lentigious and others), by gender (male and female), by
treatment (immunotherapy, biologic therapy, radiation therapy, chemotherapy,
surgery and others), by diagnosis (ABCDE, ugly duckling, biopsy, and others)
and by end users (hospitals, pharmaceutical companies, research centers,
clinics, laboratories).
Regional Analysis of Melanoma Market:
Melanoma market in the US is divided into states comprising
of Georgia, New Jersey, North Carolina, New York, Florida, Illinois, Ohio,
Pennsylvania, Texas, Washington, California and, Virginia and Rest of US.
California accounts for the largest market for melanoma in US followed by
Florida and Ohio. California and Florida are key regions for melanoma market.
Large number of melanoma cases are found in this region. New York is the
third largest market after Florida. According to American Society of Dermatology,
prevalence of melanoma is gradually increasing. and this spreads across
the body. Number of skin cancer patients is growing steadily in Florida and
Texas. This is due to their exposure to ultraviolet rays and extensive use of
tanning beds in these regions. Technological advancement in the field of
treatment and diagnosis of melanoma in the US also drives this market.
The Food and Drug Administration (FDA) classifies tanning beds as
"moderate risk" devices.
Key Players for Melanoma Market:
Some of the Key Players in this market are: Amgen, Inc.,
Bristol-Myers Squibb, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Genentech Inc.
Janssen Biotech, Inc., and Novartis International AG. Pfizer, Vical and
Ziopharm.
The report for US melanoma market of Market Research Future
comprises of extensive primary research along with the detailed analysis of
qualitative as well as quantitative aspects by various industry experts, key
opinion leaders to gain the deeper insight of the market and industry
performance. The report gives the clear picture of current market scenario
which includes historical and projected market size in terms of value and
volume, technological advancement, macro economical and governing factors in
the market. The report provides details information and strategies of the top
key players in the industry. The report also gives a broad study of the
different markets segments and regions.
Browse More Details @ https://www.marketresearchfuture.com/reports/us-melanoma-market-2950
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune -
411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment